This website uses cookies to enhance the user experience.
K

KAPPA SOLUTIONS AS882 512 142

Research
Limited company
4. etasje Silurveien 2B 0380 OSLO, Norge

KAPPA SOLUTIONS AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO
Chairman of the board
Years since formation
24 years
since Oct 23, 2000
Type
Limited company
VAT registered
Yes
Number of employees
11

Ownership

Number of shares and share classes
900
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Total operating income 2023
21,915,171
NOK
Annual total result 2023
3,200,631
NOK
Total equity 2023
16,460,708
NOK
Last update: Oct 14, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-
Board Member-

Others

NameRoleShares
R
RSM NORGE AS
Auditor-
S
STABEKK REGNSKAPSSERVICE AS
Accountant-
Last update: Jan 24, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
K
KAPPA BIOSCIENCE AS
Ordinary shares
900
100 %
Last update: May 24, 2024

Group structure

  • Total operating income 2023: NOK 0
    Operating profit 2023: NOK -158,419
    Employees: 0

Financials

in NOK

Summary

Year20232022
Total operating income
21,915,171
21,699,546
Annual Total Result
3,200,631
4,282,688
Total assets
21,590,012
18,649,835
Total liabilities
5,129,304
5,389,758
Total equity
16,460,708
13,260,077

P&L

Year20232022
Total operating income
21,915,171
21,699,546
Total operating costs
18,220,562
16,347,550
Operating result
3,694,609
5,351,996
Financial income/costs
408,763
139,342
Profit before tax
4,103,372
5,491,338
Total tax & extraordinary income/cost
902,741
1,208,650
Annual Total Result
3,200,631
4,282,688

Balance overview

Year20232022
Total fixed assets
11,108,122
10,953,461
Total current assets
10,481,890
7,696,374
Total assets
21,590,012
18,649,835
Short term debt
5,129,304
5,389,758
Long term debt
0
0
Total liabilities
5,129,304
5,389,758
Contributed capital
200,000
200,000
Retained earnings
16,260,708
13,060,077
Total equity
16,460,708
13,260,077
Total equity and liabilities
21,590,012
18,649,835

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology